Oropharyngeal Cancers Recruiting Phase 3 Trials for Durvalumab (DB11714)

Also known as: Oropharyngeal Cancer / Cancer of Oropharnyx

IndicationStatusPhase
DBCOND0042409 (Oropharyngeal Cancers)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04116047CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)Treatment